© 2020 MJH Life Sciences and Urology Times. All rights reserved.
Sexual Dysfunction
Sexual dysfunction: Protocol decreases opioid requirements in IPP patients
July 20, 2018
The AUA 2018 sexual dysfunction take-home messages also included a novel end-to-side nerve grafting procedure for men with post-radical-prostatectomy ED as well as the finding that use of a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor does not appear to change the adverse effect profile of flibanserin (Addyi).
AUA ’18: Experts pick this year’s key research
May 08, 2018
To help you sift the enormous scientific program and prioritize your schedule at the AUA annual meeting, the editors have called upon Urology Times’ editorial advisory board to identify the key research across multiple areas of the specialty.
Streamlined management of Peyronie’s disease
February 01, 2018
In this article, we describe our thought processes in treating patients with Peyronie's disease, which are summarized in an algorithm.
Penile transplant guidelines missing in action
January 01, 2018
There are no national or international guidelines regarding penile transplants, raising a question without a concrete answer: What are the rules and the limits?
Progress on penile transplant moves forward
January 01, 2018
"[Penile transplantation] is a real advance for patients who have a penile deficiency or penile loss," says Arthur L. Burnett, II, MD, MBA.
Survey: Urologists lack knowledge, training in transgender care
November 20, 2017
While urologists are generally comfortable discussing patients’ sexual orientation, they report that both their knowledge of care of transgender patients and training in such care are lacking.
Shock waves may change future of ED therapy
November 17, 2017
It’s hard to argue against an erectile dysfunction treatment that is potentially disease modifying, is noninvasive, and seems to do no harm. The treatment, low-intensity shock wave therapy, has yet to earn the FDA’s approval but is widely used in other countries. Early results from ongoing U.S. trials are promising.
New Products: FDA approves treatment for complicated UTI
October 11, 2017
Other products and services discussed in this round-up include a biosimilar for cancer, an American College of Surgeons manual on quality initiatives, a kidney cancer microsite, and more.
Uro Pipeline: Supplemental application submitted for advanced RCC treatment
August 15, 2017
Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.